(b)(4).Date sent: 1/9/2023.Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Additional information received: patient identifier: (b)(6), (b)(6) hospital, (b)(6), sex: male, age (at time of consent): 58 years.Start date: 15 sep 2022, alert date: 08- dec- 2022, country of event: ous, model: lxm16, device lot number: 26799, date of surgery: (b)(6) 2022 , adverse event term: painful urinary retention post surgery, site awareness date: (b)(6) 2022 , end date: (b)(6) 2022 , severity: mild, is the adverse event serious? yes, no required in-patient hospitalization or prolongation of existing hospitalization: yes, admission date: (b)(6) 2022 discharge date: (b)(6) 2022 , none: yes, relationship to primary study procedure: not related, outcome: recovered/resolved, discharge date : (b)(6) 2022 - (b)(6) 2022.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : blank yes.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : yes => no relationship to study procedure : not related, possible.Hospital stay was from sept (b)(6) 2022.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
(b)(4).Date sent: 1/20/2023.Investigation summary an analysis of the product could not be performed since a physical sample was not received for evaluation.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.However, if the product is received at a later date, the investigation will be updated as applicable.A manufacturing record evaluation was performed for the finished device batch number 26799 , and no related non-conformances were identified.
|
(b)(4); date sent: 2/7/2023.Additional information received: required in-patient hospitalization or prolongation of existing hospitalization: yes.Admission date: (b)(6) 2022; discharge date: (b)(6) 2022.Relationship to primary study procedure: possible.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : no /yes.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : yes /n/a.
|